ropinirole tablet film coated extended release
1 INDICATIONS AND USAGE Ropinirole extended-release tablets are non-ergoline dopamine agonist indicated for the treatment of Parkinson’s disease. ( 1) Ropinirole extended-release tablets are indicated for the treatment of Parkinson’s disease.
dr. reddys laboratories limited
OVAL BROWN R4
Related Pills
ropinirole tablet film coated extended release
dr. reddys laboratories limited
ropinirole tablet film coated extended release
dr. reddys laboratories limited
ropinirole tablet film coated extended release
dr. reddys laboratories limited
ropinirole tablet film coated extended release
dr. reddys laboratories limited
Rosuvastatin 10 mg
camber pharmaceuticals, inc.
Rosuvastatin calcium 10 mg
Camber Pharmaceuticals, Inc.
Rosuvastatin calcium 10 mg
Camber Pharmaceuticals, Inc.
Rosuvastatin calcium 10 mg
Camber Pharmaceuticals, Inc.
Rosuvastatin 10 mg
Camber Pharmaceuticals, Inc.
DISCLAIMER:
"This tool does not provide medical advice, and is for informational and educational purposes only, and is not a substitute for professional medical advice, treatment or diagnosis. Call your doctor to receive medical advice. If you think you may have a medical emergency, please dial 911."
"Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service."
"This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product."
PillSync may earn a commission via links on our site
16 HOW SUPPLIED/STORAGE AND HANDLING Each biconvex, capsule-shaped, film-coated tablet contains
ROPINIROLE hydrochloride equivalent to the labeled amount of
ROPINIROLE as follows:
ROPINIROLE extended-release tablets USP, 2 mg are pink colored, capsule shaped, biconvex, film-coated tablets debossed ‘R2’ on one side and plain on the other side and are supplied in bottles of 30, 90 and 500. Bottles of 30 NDC 55111-659-30 Bottles of 90 NDC 55111-659-90 Bottles of 500 NDC 55111-659-05
ROPINIROLE extended-release tablets USP, 4 mg are light brown colored, capsule shaped, biconvex, film-coated tablets debossed ‘R4’ on one side and plain on the other side and are supplied in bottles of 30, 90 and 500. Bottles of 30 NDC 55111-661-30 Bottles of 90 NDC 55111-661-90 Bottles of 500 NDC 55111-661-05
ROPINIROLE extended-release tablets USP, 6 mg are white colored, capsule shaped, biconvex, film-coated tablets debossed ‘R6’ on one side and plain on the other side and are supplied in bottles of 30, 90 and 500. Bottles of 30 NDC 55111-727-30 Bottles of 90 NDC 55111-727-90 Bottles of 500 NDC 55111-727-05
ROPINIROLE extended-release tablets USP, 8 mg are brick red colored, capsule shaped, biconvex, film-coated tablets debossed ‘R8’ on one side and plain on the other side and are supplied in bottles of 30, 90 and 500. Bottles of 30 NDC 55111-662-30 Bottles of 90 NDC 55111-662-90 Bottles of 500 NDC 55111-662-05
ROPINIROLE extended-release tablets USP, 12 mg are light green colored, capsule shaped, biconvex, film-coated tablets debossed ‘R12’ on one side and plain on the other side and are supplied in bottles of 30, 90 and 500. Bottles of 30 NDC 55111-728-30 Bottles of 90 NDC 55111-728-90 Bottles of 500 NDC 55111-728-05 Storage Store at 20°C to 25°C (68°F to 77°F) [see USP Controlled Room Temperature]. Dispense in a tight, light-resistant container as defined in the USP.
More pills like OVAL R4